Matthew Biegler
Stock Analyst at Oppenheimer
(0)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ACRV Acrivon Therapeutics | Maintains: Outperform | 9 8 | 1.22 | 555.74% | 3 | Aug 14, 2025 | |
NRIX Nurix Therapeutics | Reiterates: Outperform | 32 30 | 9.64 | 211.2% | 2 | Jul 31, 2025 | |
CTMX CytomX Therapeutics | Initiates Coverage On: Outperform | 7 | 2.31 | 203.03% | 1 | Jul 31, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Outperform | 10 9 | 1.03 | 773.79% | 2 | May 14, 2025 | |
OLMA Olema Pharmaceutical... | Maintains: Outperform | 25 22 | 4.57 | 381.4% | 6 | May 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 12 | 9.19 | 30.58% | 5 | May 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 8 8 | 1.99 | 302.01% | 7 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 45 | 6.58 | 583.89% | 5 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 105 115 | 120.57 | -4.62% | 1 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 53 53 | 22.84 | 132.05% | 5 | Oct 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 33 | 10.1 | 226.73% | 6 | Sep 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 20 20 | 1.4 | 1328.57% | 7 | Sep 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 6 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 114 125 | 129.46 | -3.45% | 5 | Jul 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 4 | Jul 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 14 | 6.35 | 120.47% | 5 | May 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 1 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 33 44 | 64.97 | -32.28% | 1 | Mar 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 5 | Feb 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Perform | n/a | n/a | n/a | 2 | Feb 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 8 3 | n/a | n/a | 4 | Aug 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1500 450 | 1.71 | 26215.79% | 5 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | 28 | 7.14% | 1 | Jun 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Dec 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 2 | Dec 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 520 360 | 8.87 | 3958.62% | 1 | Nov 30, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Perform | n/a | n/a | n/a | 3 | Feb 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 115 105 | n/a | n/a | 3 | Jan 21, 2022 |